Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00287573 · ClinicalTrials.gov registry record · Phase 2
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis
A Phase 2 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 488
- Enrollment target
NCT00287573: Completed Phase 2 study, sponsored by Boston Scientific Corporation.
NCT00287573 is a Phase 2 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 488 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (267% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00287573, a Phase 2 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 488 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and effectiveness of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System as compared to brachytherapy in patients experiencing in-stent restenosis.
Interventions
- DEVICE TAXUS Express2
- PROCEDURE Brachytherapy (beta source)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2003-06 |
| Est. Completion | 2010-01 |
| Phase | Phase 2 |
What the finished NCT00287573 record still lists
NCT00287573 is an interventional study that assigns participants to a tested intervention. The registered 488 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (267% higher).
The record links to 0 conditions, and to 2 interventions - of which TAXUS Express2 is the first listed.
NCT00287573 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00287573 about?
NCT00287573 is a clinical study titled "Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis". The objective of this study is to evaluate the safety and effectiveness of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System as compared to brachytherapy in patients experiencing in-stent restenosis.
What is the current status of trial NCT00287573?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 488 participants. The study started on 2003-06. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00287573?
The interventions under investigation include: TAXUS Express2 (DEVICE), Brachytherapy (beta source) (PROCEDURE).
Who is sponsoring clinical trial NCT00287573?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00287573's enrollment target sits among peer trials
488 76th of 2000 higher than 1,925 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05154669 · 488 participants · Phase 3
Integrating Financial Coaching and Smoking Cessation Coaching
- NCT06532877 · 488 participants · NA
Telephone Support in Advanced Gastrointestinal Cancer
- NCT06602479 · 488 participants · Phase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- NCT06794983 · 488 participants · NA
Calls and Coordination for Transitions of Care at Re-entry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia